Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs (English, HTML)

View metadata and access the original English HTML file: Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs.

Format

HTML

Access

file-only

Publisher-reported update

2021-12-29

Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.

Access original file